Suppr超能文献

线粒体 DNA 含量可能不是单倍体囊胚移植后活产的可靠筛查生物标志物。

Mitochondrial DNA Content May Not Be a Reliable Screening Biomarker for Live Birth After Single Euploid Blastocyst Transfer.

机构信息

International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, China.

出版信息

Front Endocrinol (Lausanne). 2021 Nov 16;12:762976. doi: 10.3389/fendo.2021.762976. eCollection 2021.

Abstract

An increasing number of studies have related the mitochondrial DNA (mtDNA) content to embryo viability and transfer outcomes. However, previous studies have focused more on the relationship between mtDNA and embryo implantation, few studies have studied the effect of the mtDNA content on live birth. In the study, we investigated whether mtDNA content is a reliable screening biomarker for live birth after single blastocyst transfer. A total of 233 couples with 316 blastocyst stage embryos undergoing fertilization treatment and pre-implantation genetic testing analysis were included in the study. All embryos were chromosomally normal and had undergone single-embryo transfers. There was no significant difference observed in the blastocyst mtDNA content among the live birth, miscarriage and non-implanted groups (p=0.999), and the mtDNA content in blastocysts from the miscarriage and live birth groups was similar [median (interquartile range), 1.0010(7.5910- 1.3910) 1.0110 (7.3710- 1.3210)]. Similarly, no significant association was observed between mtDNA content and embryo implantation potential (p=0.965). After adjusting for multiple confounders in a logistic regression analysis with generalized estimating equations, no associations between mtDNA content and live birth were observed in all blastocysts, Day-5 and Day-6 blastocysts (p=0.567, p=0.673, p=0.165, respectively). The live birth rate was not significantly different between blastocysts with an elevated mtDNA content and blastocysts with a normal mtDNA content (26.7% 33.6% p=0.780). Additionally, there was no linear correlation between the mtDNA content and maternal age (p=0.570). In conclusion, the mtDNA content does not seem to be a potential biomarker for embryo transfer outcomes (i.e., implantation and live birth) based on the existing testing tools. Embryos with an elevated mtDNA content also have development potential for successful live birth.

摘要

越来越多的研究将线粒体 DNA(mtDNA)含量与胚胎活力和转移结果联系起来。然而,之前的研究更多地关注 mtDNA 与胚胎着床的关系,很少有研究探讨 mtDNA 含量对活产的影响。在这项研究中,我们研究了 mtDNA 含量是否是单囊胚移植后活产的可靠筛选生物标志物。共有 233 对夫妇的 316 个囊胚期胚胎接受了受精治疗和植入前遗传检测分析。所有胚胎均为染色体正常,并进行了单胚胎移植。活产、流产和未着床组之间的囊胚 mtDNA 含量无显著差异(p=0.999),流产组和活产组囊胚 mtDNA 含量相似[中位数(四分位距),1.0010(7.5910-1.3910)1.0110(7.3710-1.3210)]。同样,mtDNA 含量与胚胎着床潜能之间也无显著相关性(p=0.965)。在广义估计方程的逻辑回归分析中,调整多个混杂因素后,所有囊胚、第 5 天和第 6 天囊胚的 mtDNA 含量与活产均无关联(p=0.567、p=0.673、p=0.165)。mtDNA 含量升高的囊胚与 mtDNA 含量正常的囊胚的活产率无显著差异(26.7%33.6%,p=0.780)。此外,mtDNA 含量与产妇年龄之间也无线性相关性(p=0.570)。总之,根据现有的检测工具,mtDNA 含量似乎不是胚胎移植结果(即着床和活产)的潜在生物标志物。mtDNA 含量升高的胚胎也有成功活产的发育潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7b0/8637898/cd76308b16f3/fendo-12-762976-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验